Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients
Abstract Genomic testing is crucial for the management of ovarian cancer. DNA from biopsies at diagnostic laparoscopies or interval debulking surgery after neoadjuvant chemotherapy, has a high failure rate. At relapse, biopsies may not be feasible. The aim of our study was to evaluate the feasibilit...
Main Authors: | Maria Kfoury, Reda El Hazzaz, Claire Sanson, Felix Blanc Durand, Judith Michels, Emeline Colomba Blameble, Roseline Tang, Audrey Le Formal, Elodie Lecerf, Sebastien Gouy, Amandine Maulard, Patricia Pautier, Etienne Rouleau, Alexandra Leary |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-023-00533-1 |
Similar Items
-
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
by: Cyril Roussel-Simonin, et al.
Published: (2023-11-01) -
Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis
by: I. E. Onnintsev, et al.
Published: (2017-06-01) -
Utility of ascitic tumor markers and adenosine deaminase for differential diagnosis of tuberculous peritonitis and peritoneal carcinomatosis
by: Li Du, et al.
Published: (2022-09-01) -
Chylous Ascites due to Mantle Cell Lymphoma
by: Ricardo Jorge Gonçalves Fernandes, et al.
Published: (2018-04-01) -
Diagnosis and Management of Chylous Ascites
by: Putu Shely Prihastuti, et al.
Published: (2023-04-01)